EarliTec Diagnostics

EarliPoint is the first FDA-indicated Autism evaluation tool for children as young as 16 months. The EarliPoint Evaluation can be operated by any trained clinic employee, freeing the physician's time for interpretation of the objective measurements reported within the EarliPoint Evaluation. The EarliPoint evaluation session takes approximately 12 minutes. This technology enables pediatric practices to quickly and accurately evaluate children when concerns arise during their 18 and 24-month ASD screenings. Peer-reviewed, double-blinded, published studies have demonstrated that the EarliPoint Evaluation can replicate the accuracy of the nation's expert autism diagnosticians. 

No other autism evaluation knows how a child sees the world! Utilizing Social-Visual Engagement, the technology captures a child's moment-by-moment looking behavior at a rate of 120 times per second, which is otherwise imperceptible to the human eye. By measuring an individual child's looking behavior and comparing these data points to those of typically developing peers, EarliPoint provides information that aids physicians in the earlier identification of autism. EarliPoint also provides three valuable objective biomarker indices that measure disengagement and social skills, forecast receptive/expressive language, and profile the child's visual-problem-solving skills. These three indices can be helpful in therapy planning and objectively measuring the child's progress serially.